Search Result "NSCLC inhibitors"
Irreversible EGFR Inhibitors in the Treatment of Advanced NSCLC
Journal: Current Pharmaceutical Design
Volume: 20 Issue: 24 Year: 2014 Page: 3894-3900
Author(s): Paolo Maione,Antonio Rossi,Marianna Bareschino,Paola Claudia Sacco,Clorinda Schettino,Francesca Casaluce,Assunta Sgambato,Cesare Gridelli
Overcoming Resistance to EGFR Inhibitors in NSCLC
Journal: Reviews on Recent Clinical Trials
Volume: 11 Issue: 2 Year: 2016 Page: 99-105
Author(s): Paolo Maione, Paola C. Sacco, Francesca Casaluce, Assunta Sgambato, Giuseppe Santabarbara, Antonio Rossi, Cesare Gridelli
Therapeutic Uses of HSP90 Inhibitors in Non-Small Cell Lung Carcinoma (NSCLC)
Journal: Current Drug Metabolism
Volume: 19 Issue: 4 Year: 2018 Page: 335-341
Author(s): Anam Akram,Sara Khalil,Sobia Ahsan Halim,Hooria Younas,Sadaf Iqbal,Saima Mehar
A Review on the Antitumor Activity of Various Nitrogenous-based Heterocyclic Compounds as NSCLC Inhibitors
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 19 Issue: 18 Year: 2019 Page: 1517-1530
Author(s): Jia-Chun Liu,Suresh Narva,Kang Zhou,Wen Zhang
Current Molecularly Targeting Therapies in NSCLC and Melanoma
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 15 Issue: 7 Year: 2015 Page: 856-868
Author(s): Supriya Rajanna,Ichwaku Rastogi,Luke Wojdyla,Hiroko Furo,Agnes Kulesza,Leo Lin,Bonnie Sheu,Mark rakes,Marko Ivanovich,Neelu Puri
MET and ALK as Targets for the Treatment of NSCLC
Journal: Current Pharmaceutical Design
Volume: 20 Issue: 24 Year: 2014 Page: 3914-3932
Author(s): Capelletti M,Gelsomino F.,Tiseo M.
Selumetinib in Advanced Non Small Cell Lung Cancer (NSCLC) Harbouring KRAS Mutation: Endless Clinical Challenge to KRAS-mutant NSCLC.
Journal: Reviews on Recent Clinical Trials
Volume: 8 Issue: 2 Year: 2013 Page: 93-100
Author(s): Paolo Maione,Assunta Sgambato,Antonio Rossi,Paola Claudia Sacco,Maria Anna Bareschino,Clorinda Schettino,Francesca Casaluce,Fortunato Ciardiello,Cesare Gridelli
Nutrition and NSCLC; Should We Administer Food Supplements?
Journal: Current Pharmaceutical Design
Volume: 27 Issue: 34 Year: 2021 Page: 3602-3608
Author(s): Paul Zarogoulidis,Christoforos Kosmidis,Isaak Kesisoglou,Kosmas Tsakiridis,Wolfgang Hohenforst-Schmidt,Haidong Huang,Îonstantinos Romanidis,Anastasios Vagionas,Konstantinos Sapalidis
Structural Insights into the Molecular Design of ROS1 Inhibitor for the Treatment of Non-Small Cell Lung Cancer (NSCLC)
Journal: Current Computer-Aided Drug Design
Volume: 17 Issue: 3 Year: 2021 Page: 387-401
Author(s): Ritu Adhikary,Ravina Khandelwal,Tajamul Hussain,Anuraj Nayarisseri,Sanjeev K. Singh
Efficacy and Safety of EGFR Inhibitors in the Treatment of EGFRPositive NSCLC Patients: A Meta-Analysis
Journal: Reviews on Recent Clinical Trials
Volume: 16 Issue: 2 Year: 2021 Page: 193-201
Author(s): Amit Dang,Sumit Dang,B.N. Vallish